From: Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups
 |  |  | RT-PCR products Region | Genomic PCR products Region | ||||
---|---|---|---|---|---|---|---|---|
Case | Sample | Type of HMGA2 expression | 1 | 2 | 3 | 1 | 2 | 3 |
 | Amniocytes 1 | ND | + | + | + | ND | ND | ND |
 | Amniocytes 2 | ND | + | + | + | ND | ND | ND |
 | Amniocytes 3 | ND | + | + | + | ND | ND | ND |
4 | Lipoma t(3;12) | Differential | (+) | - | (+) | + | + | + |
4 | Peripheral blood | ND | ND | ND | ND | + | + | + |
10 | Lipoma t(5;12) | Aberrant | + | (+) | + | + | + | + |
11 | Lipoma der(12q13-15) | Differential | - | - | - | + | + | + |
13 | Lipoma der(12q13-15) | Aberrant | - | - | - | + | + | + |
17 | Variant Lipoma | Aberrant | (+) | - | (+) | + | + | + |
18 | Variant Lipoma | Aberrant | (+) | - | - | + | + | + |
18 | Peripheral blood | ND | ND | ND | ND | + | + | + |
21 | Lipoma der(6p21-22) | Differential | - | - | (+) | ND | ND | ND |
26 | Lipoma del(13q) | Differential | - | - | - | + | + | + |
26 | Peripheral blood | ND | ND | ND | ND | + | + | + |
27 | Lipoma del(13q) | Aberrant | - | - | - | ND | ND | ND |
36 | Angiolipoma | Aberrant | (+) | - | + | ND | ND | ND |
37 | Angiolipoma | Aberrant | - | - | (+) | + | + | + |
38 | Angiolipoma | Aberrant | - | - | (+) | + | + | + |
38 | Peripheral blood | ND | ND | ND | ND | + | + | + |
39 | Angiolipoma | Weak | - | - | - | + | + | + |
39 | Peripheral blood | ND | ND | ND | ND | + | + | + |
40 | Angiolipoma | Weak | - | - | - | + | + | + |
40 | Peripheral blood | ND | ND | ND | ND | + | + | + |
41 | Angiolipoma | ND | - | - | - | + | + | + |
42 | Angiolipoma | ND | - | - | (+) | + | + | + |
43 | Angiolipoma | ND | - | - | - | + | + | + |
49 | Hibernoma | Aberrant | - | - | (+) | + | + | + |